Lipid Testing After Myocardial Infarction at the Montreal Heart Institute

Sponsor
Montreal Heart Institute
Study ID
NCT06388668
Status
Recruiting
Apply to this trial

Conditions

  • Dyslipidemias
  • Lipid Testing
  • Myocardial Infarction

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Lipid panel — DIAGNOSTIC_TEST
    Lipid panel measuring levels of LDL, non-HDL and apoB

Study Details

Because treatment decisions are usually based on a single measurement of the lipid panel at the time of an admission for an MI, the overarching objective of this project is to evaluate whether the measurement of LDL, non-HDL, and apoB values are reliable through all the duration of the hospitalization. It will be a single-center, prospective, observational study will be conducted, including consecutive patients hospitalized for myocardial infarction at the Montreal Heart Institute. Every patient at the Cardiac Care Unit will undergo non-fasting lipid panel testing at day 0 of their admission for Myocardial Infarction during the study period. Patients who consent to participate will have a 2nd non-fasting lipid panel drawn at day 2 of their admission. Thereafter, the levels of the different lipid values from the panel will be compared between day 0, day 2, and 4-6 weeks after discharge.

Key Dates

First listed
Apr 29, 2024
Start date
Jun 1, 2024
Status verified
May 2025
Primary completion
Mar 31, 2026
Completion
May 31, 2026

Study Design

Enrollment
100 participants (estimated)

Primary Outcome Measure

Variation in LDL [ Time Frame: Day 0 to day 2 ]

Central Contacts

Related Studies